SML2929

Bilastine

≥98% (HPLC)

• Synonyme(s) : 2-[4-(2-(4-(1-(2-ethoxyethyl)benzimidazole-2-yl)piperidine-1-yl)ethyl)phenyl]-2-methyl-propanoic acid, 4-[2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethylbenzeneacetic acid, F-96221-BM1
• Formule empirique (notation de Hill) : C₂₈H₃₇N₃O₃
• Numéro CAS: 202189-78-4
• Poids moléculaire : 463.61
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD09837814
• Assay: ≥98% (HPLC)
• Form: powder

Propriétés

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: [N+H]2(CCC(CC2)c3[n](c4c(n3)cccc4)CCOCC)CCc1ccc(cc1)C(C)(C)C(=O)[O-]
• InChI: 1S/C28H37N3O3/c1-4-34-20-19-31-25-8-6-5-7-24(25)29-26(31)22-14-17-30(18-15-22)16-13-21-9-11-23(12-10-21)28(2,3)27(32)33/h5-12,22H,4,13-20H2,1-3H3,(H,32,33)
• InChI key: ACCMWZWAEFYUGZ-UHFFFAOYSA-N

Description

Biochem/physiol Actions

Bilastine is an orally available, potent and selective histamine H1 receptor antagonist that exhibits long drug-target residence time at H1 receptor (73 min), which results in extended H1 receptor antagonism in vitro. Bilastine is used for treatment of allergic rhinitis and urticaria (hives).

orally available, potent and selective histamine H1 receptor antagonist that exhibits long drug-target residence time at H1 receptor

Informations sur la sécurité

• Classe de stockage: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable